Correlation Between Avicanna and Crescita Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Avicanna and Crescita Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Avicanna and Crescita Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Avicanna and Crescita Therapeutics, you can compare the effects of market volatilities on Avicanna and Crescita Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Avicanna with a short position of Crescita Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Avicanna and Crescita Therapeutics.

Diversification Opportunities for Avicanna and Crescita Therapeutics

0.03
  Correlation Coefficient

Significant diversification

The 3 months correlation between Avicanna and Crescita is 0.03. Overlapping area represents the amount of risk that can be diversified away by holding Avicanna and Crescita Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Crescita Therapeutics and Avicanna is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Avicanna are associated (or correlated) with Crescita Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Crescita Therapeutics has no effect on the direction of Avicanna i.e., Avicanna and Crescita Therapeutics go up and down completely randomly.

Pair Corralation between Avicanna and Crescita Therapeutics

Assuming the 90 days horizon Avicanna is expected to generate 15.08 times less return on investment than Crescita Therapeutics. But when comparing it to its historical volatility, Avicanna is 6.48 times less risky than Crescita Therapeutics. It trades about 0.02 of its potential returns per unit of risk. Crescita Therapeutics is currently generating about 0.05 of returns per unit of risk over similar time horizon. If you would invest  56.00  in Crescita Therapeutics on November 2, 2024 and sell it today you would lose (17.00) from holding Crescita Therapeutics or give up 30.36% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy99.4%
ValuesDaily Returns

Avicanna  vs.  Crescita Therapeutics

 Performance 
       Timeline  
Avicanna 

Risk-Adjusted Performance

1 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Avicanna are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. Despite nearly fragile basic indicators, Avicanna reported solid returns over the last few months and may actually be approaching a breakup point.
Crescita Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Crescita Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain nearly stable which may send shares a bit higher in March 2025. The current disturbance may also be a sign of long-run up-swing for the company stockholders.

Avicanna and Crescita Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Avicanna and Crescita Therapeutics

The main advantage of trading using opposite Avicanna and Crescita Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Avicanna position performs unexpectedly, Crescita Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Crescita Therapeutics will offset losses from the drop in Crescita Therapeutics' long position.
The idea behind Avicanna and Crescita Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Commodity Channel module to use Commodity Channel Index to analyze current equity momentum.

Other Complementary Tools

Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
CEOs Directory
Screen CEOs from public companies around the world
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences